Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Terminated

2(33%)

Phase Distribution

Ph not_applicable

17%

Ph phase_4

17%

Ph phase_3

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 3Large-scale testing

3(60.0%)

Phase 4Post-market surveillance

1(20.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Terminated(2)

Detailed Status

Recruiting2

Terminated2

Completed2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 33 (60.0%)

Phase 41 (20.0%)

N/A1 (20.0%)

Trials by Status

recruiting233%

terminated233%

completed233%

Recent Activity

2 active trials

Showing 5 of 6

recruitingphase_4

Clinical Trials (6)

Showing 6 of 6 trials

NCT05137119Phase 4

Staphylococcus Aureus Network Adaptive Platform Trial

Recruiting

NCT06504888

Do Penicillin-allergic Patients Presents a High Risk of Sinus Lift Failure

Recruiting

NCT00000585Phase 3

Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

Completed

NCT00315042Phase 3

TELI TON - Telithromycin in Tonsillitis

Terminated

NCT00315549Phase 3

TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults

Terminated

NCT00405158Not Applicable

Study of Acupuncture and Care Interventions for the Treatment of Breast Inflammation During Breastfeeding

Completed

All 6 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 6